Skip to main content
OpenTrials
Completed

NCT Number: NCT06170658

1 Week Crossover Dispensing Study Between Two Soft Contact Lenses

The objective of this investigation is to compare the visual clinical performance of a silicone hydrogel daily disposable investigational contact lenses to a hydrogel daily disposable commercially available contact lenses.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Waterloo

Waterloo, Ontario, N2L 3G1, Canada

About this study

This is a prospective, bilateral, double masked (participant and investigator), randomized, cross-over dispensing study with 1 week wearing period in each arm by comparing visual acuity and subjective vision quality.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are 8 to 18 years of age inclusive and have full legal capacity to volunteer;
  • Have read and signed and dated the Parental Permission Form (for those aged 16 and younger); participant has read, signed and dated the study Information Consent Letter (if aged 17 or 18 years) or Assent (aged 16 and younger);
  • Are willing and able to follow instructions and maintain the appointment schedule;
  • Are habitual daily wearers of spherical single vision soft contact lenses to correct for distance vision in each eye;
  • Currently wears spherical soft contact lenses or myopia control soft lenses;
  • Have a pair of wearable back-up spectacles;
  • Are willing and able to wear contact lenses for at least 10 hours a day, 6 days a week while in the study;
  • Are myopic with subjective refraction: -0.75D to -7.00D spherical, with an astigmatism ≤ -0.75D in each eye with maximum spherical equivalent anisometropia of 1.00D
  • Are correctable to a visual acuity of +0.10 logMAR or better (in each eye) with sphero-cylindrical subjective refraction;
  • Have clear corneas with no corneal scars or any active ocular disease;
  • Can be fit with the study contact lenses with a power between -0.75 and -7.00 DS; this translates to best corrected vision sphere refraction that vertexes to a CL power between -0.75 and -7.00 (inclusive) at screening visit.
  • Demonstrate an acceptable fit with the study lenses.
  • Demonstrate that they can safely and independently insert and remove contact lenses at the screening/fitting visit;

Exclusion criteria

  • Have taken part in another clinical research study within the last 14 days;
  • Are currently habitual wearers of toric lenses.
  • Have worn any rigid contact lenses or ortho-keratology lenses in the past 30 days
  • Are an extended lens wearer (i.e., sleeping with their lenses)
  • Are on ongoing atropine treatment for myopia control
  • Have a difference of > 1.0 D in best vision sphere subjective refraction between eyes;
  • Have amblyopia and/or strabismus/binocular vision problem
  • Have any known active ocular disease, allergies and/or infection;
  • Have a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  • Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  • Have a known sensitivity to the diagnostic pharmaceuticals to be used in the study;
  • Have undergone refractive error surgery or intraocular surgery;
  • Are a member of CORE directly involved in the study.

Treatment and study plan

Test Lenses (stenfilcon A)

Device

Daily disposable, silicone hydrogel investigational lenses for one week

Control Lenses (omafilcon A)

Device

Daily disposable, hydrogel commercially available lenses for one week

Primary outcomes

  1. High contrast, binocular, distance visual acuity

    Time frame: 7 days

    Distance visual acuity (LogMAR) will be measured using high and low contrast computer-generated acuity charts.

Secondary outcomes

  1. Subjective Vision Quality

    Time frame: 7 days

    Subjective vision quality on 0-100 scale, integer steps (0 = Very poor; 100 = Excellent vision, totally sharp)

Sponsors and collaborators

Lead sponsor

CooperVision, Inc.

Industry

Registry information

Official study title

1 Week Crossover Dispensing Study: Buttermere Versus MiSight 1 Day Soft Contact Lenses

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Dec 14, 2023
Registry last updated
Aug 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.